Merkel Cell Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials

Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer
Conditions:   Merkel Cell Carcinoma;   Small Cell Lung Cancer Interventions:   Biological: XmAb18087;   Drug: XmAb18087 ± Pembrolizumab Sponsors:   Xencor, Inc.;   ICON plc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials

Targeted Therapy and Avelumab in Merkel Cell Carcinoma
Condition:   Metastatic Merkel Cell Carcinoma Interventions:   Drug: Avelumab;   Radiation: External Beam Radiation Therapy (EBRT);   Radiation: Lutetium-177 (177Lu)-DOTATATE Sponsor:   Melanoma and Skin Cancer Trials Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 10, 2020 Category: Research Source Type: clinical trials